The Steadman Clinic Uses Modernizing Medicine’s Telehealth Solution to Treat Patients During COVID-19 Pandemic

    NEXT STORY
    Phase 3 Clinical Trial of Tedopi®: OSE Immunotherapeutics Announces Positive Top-Line Results for Step-1 of its trial ‘Atalante 1’ in Non-Small Cell Lung Cancer
    PREV STORY
    iTeos Therapeutics Closes $125 Million Series B2 Financing
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Mustang Bio Announces Appointment of Manuel Litchman, M.D., as President and Chief Executive Officer

    NEW YORK, April 24, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”), a Fortress ...

    author_avatar
    NASDAQ Market News

    BeyondSpring to Present Clinical Trial Data on Lead Asset, Plinabulin, at 2019 St. Gallen International Breast Cancer Conference

    author_avatar
    NASDAQ Market News

    Gemphire Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

    LIVONIA, Mich., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a ...

    author_avatar
    NASDAQ Market News